[Severe asthma, IgE and anti-IgE: from sceptical waiting to factual learning].
Blanc
F X
FX
D000293:Adolescent; D018927:Anti-Asthmatic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D001249:Asthma / Q000188:drug therapy* / Q000276:immunology; D002648:Child; D017326:Clinical Trials, Phase III as Topic; D018849:Controlled Clinical Trials as Topic; D006801:Humans; D007073:Immunoglobulin E / Q000276:immunology / Q000502:physiology*; D000069444:Omalizumab; D011788:Quality of Life; D012130:Respiratory Hypersensitivity / Q000276:immunology*
D018927:Anti-Asthmatic Agents; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069444:Omalizumab; D007073:Immunoglobulin E